In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

called ReliOn insulin, which sells for as little as $25. The pharmaceutical company Novo Nordisk has products sold under the Novolin brand name, and Eli Lilly manufactures them under the Humulin name.

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) benefit from innovative treatments for obesity and diabetes. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day.

Clarivate’s Drugs to Watch in 2025 report (PDF) predicts that Novo’s new once-weekly insulin Awiqli will pick ... Novo and Eli Lilly have been duking it out in the fields of diabetes and ...

Following the first approval of generic versions of type 2 diabetes drug, Actos, the FDA has also approved updated prescribing information for Tradjenta tablets, for add-on therapy to insulin ...

In this other section I will discuss another key component of Novo Nordisk and Eli Lilly's revenues, namely the insulin market. Typically when we invest in a pharmaceutical company, the first ...

It said that may be at odds with the FDA's view. Insurers generally cover Lilly's and Novo's drugs for diabetes, but many do not cover the weight-loss medications. That has led many patients to ...

surpassing Novo Nordisk's Wegovy (semaglutide),” GlobalData said in a report the market research firm released Tuesday. “Recently, Eli Lilly announced the results from its SURMOUNT-5 trial ...

Global pharma major Lupin Limited on Monday announced the acquisition of Huminsulin in India from Eli Lilly and Company ... range of products comprising of Insulin Human, including Huminsulin ...

Lupin Ltd has announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly ... Huminsulin range of products comprising of Insulin Human, including Huminsulin R, Huminsulin ...